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Abstract
Background: The 2009 H1N1 pandemic left a legacy of mistrust in the public relative to how outbreaks of emerging
infectious diseases are managed. To prepare for future outbreaks, it is crucial to explore the phenomenon of public trust in
the institutions responsible for managing disease outbreaks. We investigated the evolution of public trust in institutions
during and after the 2009 pandemic in Switzerland. We also explored respondents’ perceptions of the prevention campaign
and the roles of the government and media.
Methodology/Principal Findings: A two-wave longitudinal survey was mailed to 2,400 members of the Swiss public. Wave
1 was in Spring 2009. Wave 2 was in Spring 2010. Six hundred and two participants responded in both waves. Participants
indicated moderate to high levels of trust in medical organizations, the WHO, the Swiss government, the pharmaceutical
industry, and the EU. On the other hand, trust in the media was low. Moreover, trust in almost all institutions decreased over
time. Participants were satisfied with the amount of information received and indicated having followed official
recommendations, but widespread concerns about the vaccine were evident. A large majority of participants agreed the
vaccine might have unknown or undesirable side effects. Perceptions of the government’s and the media’s role in handling
the outbreak were characterized by a substantial degree of skepticism and mistrust.
Conclusions/Significance: Results show clear patterns of skepticism and mistrust on the part of the public relative to
various institutions and their actions. Results underscore the importance of systematically investigating trust of the public
relative to epidemics. Moreover, studies investigating the evolution of the public’s memories of the pandemic over the
coming years may be important to understand reactions to future pandemics. A systematic research program on trust can
inform public health communication campaigns, enabling tailored communication initiatives.
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Introduction
On August 10, 2010, the end of the 2009 H1N1 pandemic was
officially declared by the World Health Organization [1]. The
timeline of the disease and related consequences are well known.
Soon after its initial emergence in Mexico and the USA, H1N1
(swine flu) spread rapidly over the planet, prompting the WHO to
declare the pandemic alert phase on June 11, 2009, in effect
instituting the first influenza pandemic of the 21st century. Nations
worldwide ordered millions of doses of vaccine, many of which
arrived after the main waves of infections peaked, in the final
months of 2009. Vaccination rates were low [2]. In the aftermath
of the vaccination campaigns, many countries were left with
substantial quantities of unused vaccine. The epidemiological
consequences of the pandemic were much less serious than
expected and public health concerns have since shifted from classic
issues like containing the disease spread and limiting its impact on
human societies to an unprecedented issue that has since emerged,
namely a crisis of public trust in the national and international
institutions involved in managing the disease outbreak [3].
Social science research on trust distinguishes between trust in
the competence or the motives of an agent or an institution [4,5]. The
crisis of public trust involves both aspects. There does seem to be
widespread mistrust regarding institutional competence in man-
aging disease outbreaks. An example is the belief that the vaccine
has serious side effects that are currently unknown to scientists [6].
Another example is skepticism on the part of the public towards
the accuracy of official risk assessments of infectious diseases like
H5N1 and H1N1 influenza, as well as the utility or efficacy of
institutional action. On the other hand, there also seems to be
a widespread mistrust regarding the motives of institutions in
managing disease outbreaks. An example of this is the belief that
risk has been intentionally exaggerated by powerful interest groups
for ulterior motives [7]. Both types of mistrust require urgent
attention on the part of researchers.
Public mistrust may have its proximate origins in the 2005–2006
H5N1 outbreak, but potentially hark back to earlier affairs like the
counterproductive 1976 swine flu vaccination campaign [8] or
even the Tuskegee syphilis experiments that have left a lingering
legacy of mistrust in some social groups [9]. It is also possible that
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the current crisis has been influenced by the related issue of
vaccination skepticism that is propagated by vocal activist groups
through the media [10] and is gaining credence in the mainstream
public [11]. The handling of the pandemic by organizations like
the WHO has come under critical scrutiny from political and
scientific authorities as well as journalists [12], who have raised
accusations of conflict of interest. More generally, perceptions of
government ‘‘cover-up’’ in various past food and health scares
(e.g., mad cow disease) may also affect trust in the long term.
These events may influence public sentiment that non-profit
organizations or governments are influenced by the pharmaceu-
tical industry, with some commentators even suggesting that the
outbreak was purposely engineered to sell vaccine [13].
The crisis of public trust has important negative effects. People
who believe that the swine flu outbreak was exaggerated are less
prone to change their behavior to comply with recommended
protection measures [14]. Beliefs that the virus is not severe are
associated with decreased vaccination intent [15]. And actual
vaccination uptake is predicted by prior trust in medical
organizations [16]. But perhaps the most far-reaching potential
effects of the crisis may emerge in the long term, by detrimentally
affecting the public’s reactions to future influenza outbreaks,
leading to fewer changes in behavior, reduced compliance and,
ultimately, failure of health campaigns. Analyses of other cases of
failed health programs suggest that this is a plausible outcome [3].
Understanding public trust relative to emerging influenza
outbreaks thus becomes a significant priority, both in itself and
in preparation for future disease outbreaks. Unfortunately, little is
currently known about this topic. Trust needs to be studied in
a more differentiated manner distinguishing between trust in
competence and motives as well as whether they lead to different
behavioral outcomes. Studies should also ascertain which institu-
tions are trusted and which are not. Moreover, data on the content
of public perceptions of how the crisis was handled are needed.
Finally, it is necessary to explore how levels of trust fluctuate over
time, in other words, longitudinal studies are needed. Current
research fails on several of these aspects. Studies of public
perceptions are often cross-sectional in nature [17] and hence do
not permit tracing dynamic evolutions. Existing longitudinal
studies [18] do not explore trust in detail, e.g., by studying trust
in different institutions. At the same time, the recent influenza
outbreaks are characterized by a high degree of uncertainty which
limits the extent to which classic health communication strategies
can be applied. For example, recommendations to increase media
coverage [19] and thus set an agenda for public concerns may
backfire if trust in media reporting is low [20]. Indeed, qualitative
data suggests that media coverage of the pandemic was often
perceived as exaggerated [21,7]. But such studies often are not
representative. As a result of these issues, the evidence base on
which to design future health campaigns is thin – a worrying state
of affairs and at the same time a potential opportunity to
contribute to the process of rebuilding trust during the current
interpandemic period [3].
Our research addresses several of these issues. We conducted
a longitudinal study in Switzerland with the goal of tracking the
content and evolution of the public’s trust in various institutions
involved in managing the pandemic, between its initial outbreak in
Spring 2009 and its aftermath a year later in Spring 2010. In order
to understand the legacy of the H1N1 pandemic in the public’s
eye, we also measured the public’s perceptions in Spring 2010 of
(1) the prevention campaign, (2) the role of the government in
managing the outbreak and (3) the role of the media in covering
the outbreak.
Our study was originally designed as a two-wave longitudinal
exploration of public perceptions of avian influenza (H5N1) risk
via a survey mailed to potential participants. Wave 1 of data
collection was launched in Spring 2009. The 2009 H1N1 outbreak
serendipitously occurred during data collection. We seized the
opportunity to design Wave 2 of data collection so as to investigate
the abovementioned issues about H1N1 influenza. We thus
included questions about perceptions of the ‘‘swine flu’’ crisis
and its handling in Wave 2. However, to control for possible effects
of the H1N1 outbreak during Wave 1 data collection, we marked
Wave 1 surveys returned after the beginning of the outbreak
(Figure 1).
Given that H5N1 and H1N1 are both strains of influenza and
that their respective outbreaks occurred within a few years of each
other, the public may exhibit comparable levels of trust in
institutions regarding the management of these two diseases. On
the other hand, these two diseases differ markedly in certain
characteristics, e.g., their mortality rate. It is therefore an open
question whether the public’s perceptions of the trustworthiness of
institutions differ for the two diseases. Since Wave 1 measured
trust in institutions relative to managing H5N1, we split the sample
in Wave 2, asking half the participants to evaluate trust in
institutions relative to managing H5N1 and half to evaluate trust
in institutions relative to managing H1N1 (Figure 1). With this
design, then, half the sample evaluates trust relative to H5N1 in
Waves 1 and 2, and half the sample evaluates trust relative to
H5N1 in Wave 1 and trust relative to H1N1 in Wave 2. This
allows us to ascertain with precision whether the public’s trust is
different for these two diseases or not.
Methods
Ethics Statement
The University of Neuchaˆtel and the University of Lausanne do
not have institutional review boards for psychology or social
science research. We thus applied the ethical standards of the
Swiss Psychological Society, via its recommended ethics checklist
(‘‘Checkliste fu¨r die ethische Beurteilung von Psychologischen
Forschungsvorhaben’’, see www.ssp-sgp.ch/ethik.htm). According
to this checklist, our questionnaire avoids any treatment that might
have a detrimental effect on the well-being or integrity of
participants. Participants were informed about the purpose of
the study in a cover letter, and were ensured their data would
remain confidential. Agreement to participate by filling out and
returning the questionnaire was taken as consent.
Data Collection
We conducted a longitudinal study in the French-speaking part
of Switzerland. The study had two measurement points: March to
June 2009 (Wave 1) and March to June 2010 (Wave 2). We
employed a quota sampling procedure designed to obtain equal
proportions of men and women, equal proportions of three age
groups (20–39, 40–65,.65), and equal proportions of people
residing in rural or urban areas. Participants’ addresses were
selected from a large commercial database. For Wave 1, 2,400
adult participants were sent a questionnaire by mail, together with
a pre-paid return envelope, addressed to the university. We
followed up on the initial contact with a reminder letter three
weeks later. Nine hundred fifty questionnaires were mailed back
(response rate = 39.6%). Respondents were contacted again one
year later, to participate in Wave 2, using the same procedures as
for Wave 1. Six hundred two usable questionnaires were returned
(response rate = 63.4%). In both waves, participants received
20 CHF for filling out the questionnaire. As outlined above
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(Figure 1), questionnaires in Wave 1 focused on perceptions of
H5N1. To control for the outbreak of H1N1 during the data
collection, questionnaires were coded as having been returned
before (n=450) or after the H1N1 outbreak (n=152). In Wave 2,
half of the respondents (n=295) filled out a questionnaire on
perceptions of H1N1, the other half (n=307) on perceptions of
H5N1. The H5N1 questionnaire also featured some items about
H1N1 (see Measures below). Importantly, we only aggregated the
data of Wave 2 across the two main target diseases if preliminary
analyses indicated that there were no differences in disease
perceptions.
Measures
In Wave 1, we assessed participants’ gender, subjective health
and germ aversion [24] as control variables. In Wave 2, we
assessed perceptions of the disease prevention campaign and
perceptions of the roles played by the government and the media.
Questions were designed to capture key elements of public
sentiment as identified in earlier qualitative studies [7]. In both
waves, we assessed trust in eight institutions involved in dealing
with either H5N1 (Wave 1) or H1N1/H5N1 (Wave 2), thus
allowing us to analyze changes in trust. Measures are described in
detail below. If not indicated otherwise, participants indicated
their responses on 5-point Likert scales using the following
anchors: 1 = do not agree at all, 2 = do not agree, 3 = agree somewhat,
4 = agree, 5 = strongly agree).
Subjective health. In Wave 1, subjective health was mea-
sured with one item How is your health in general? (1 = very bad, 2 = bad,
3 = okay, 4 = good, 5 = very good; M=4.10, SD=0.73).
Germ aversion. Germ aversion is a subscale of the Perceived
Vulnerability to Disease scale [24]. Germ aversion captures inter-
individual differences with respect to ‘‘discomfort in situations that
connote an increased likelihood for the transmission of pathogens’’
(p. 545) [24]. Sample items are It really bothers me when people sneeze
without covering their mouths or I prefer to wash my hands pretty soon after
shaking someone’s hand. Items were averaged into one scale, with
higher values indicating higher levels of germ aversion (a=0.74,
M=2.50, SD=0.64).
Trust in institutions. Trust in institutions pertaining to
combating the virus was measured in Waves 1 (H5N1) and 2 (both
H5N1 and H1N1). Participants’ indicated their level of trust
(1 = no trust at all, 5 = a lot of trust) in eight institutions: the Swiss
government, governments of countries where the virus has affected humans, the
European Union, the World Heath Organization, medical organizations, the
agro-food industry, the pharmaceutical industry, and the media. Items
showed high internal consistency in both waves (Wave 1 a= .83,
Wave 2 a= .86), but we analyzed them separately in what follows
in order to understand institution-specific trust perceptions.
Perceptions of the disease prevention
campaign. Respondents indicated their opinions relative to
the following four items: Do you think the vaccine was useful?, Did you
follow the recommendations of the Federal Office of Public Health (wash
hands, sneeze into sleeve…)?, Do you think you have received enough
information on the part of health authorities about the vaccination procedure?
and Do you think the vaccine can have unknown/problematic side effects?
Responses were made using a 5-point Likert scale (1 =No, not at all,
2 =No, 3 =Neither yes nor no, 4 = Yes, 5 =Yes, absolutely). Items
showed low internal consistency (a= .39), so we analyzed them
separately in what follows, especially in order to differentiate
among perceptions of different aspects of the campaign.
Perceptions of the role of the government. Participants’
perceptions of the role of the Swiss government in managing the
H1N1 outbreak were assessed in Wave 2 (for the H1N1
questionnaire only, n=152), with the following three items: The
government accentuated the crisis in order to exhaust Tamiflu stocks, The
government omitted or hid certain relevant facts, The government put too much
pressure on people to encourage them to get vaccinated. Items showed high
internal consistency (a= .80), but we analyzed them separately in
what follows, in order to differentiate among perceptions of
different aspects of the government’s actions.
Perceptions of the role of the media. Participants’
perceptions of the role the media played in covering the current
H1N1 outbreak or the earlier H5N1 outbreak were assessed with
five items in Wave 2: The media have exaggerated the risk posed by this
disease, Information in the media helped avoid an outbreak of cases in
Switzerland (reverse-scored), The media have omitted or hidden some
relevant facts, Extensive media reporting was necessary to attract people’s
Figure 1. Study Design.
doi:10.1371/journal.pone.0049806.g001
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attention to the dangers of the flu (reverse-scored), and One cannot trust
what one hears in the press about this disease. Items showed low internal
consistency (a= .10), so we analyzed them separately in what
follows, especially in order to differentiate among perceptions of
different aspects of the media’s actions.
Results
Respondent Characteristics
The final longitudinal sample (n=602; 342 women, mean age at
Wave 1 46.3 years, SD=15.8 years) was similar to the Swiss
population on several key characteristics except for residential
area, which we had sampled to equally represent rural and urban
populations (Table 1).
Trust in Institutions
Correlations between the control variables and the aggregated
measure of trust in institutions appear in Table 2. In general,
control variables were weakly linked to the trust measure. Women
were more trusting than men in Wave 1, but not in Wave 2. Germ
aversion correlated with trust in both waves. These results
corroborate well-established findings on individual differences in
risk perception and trust [22,23]. Trust at Wave 1 was higher for
respondents who returned the surveys after the H1N1 outbreak.
The target disease (H5N1 or H1N1) in Wave 2 was not correlated
with trust ratings.
Most importantly, trust in institutions at Wave 1 did not differ
between respondents and nonrespondents at Wave 2. A multivar-
iate analysis of variance (MANOVA) with respondents vs.
nonrespondents as between-subjects factor and trust in the eight
institutions as dependent variables revealed that overall, trust in
institutions did not differ as a function of Wave 2 respondent
status, Wilk’s L= .99, F(8, 921) = .94, ns. The global mean of the
scale is 2.99 (SD= .66) for Wave 2 nonrespondents versus 2.98
(SD= .66) for Wave 2 respondents. Moreover, none of the
univariate tests were significant, indicating that this global result
also holds for each of the institutions considered individually.
Thus, drop-outs between Waves 1 and 2 are not affected by trust
in institutions, our focal variable.
Our main purpose was to capture changes in trust in
institutions. We thus analyzed differences in trust levels between
Waves 1 and 2. We first determined if mean trust levels differed as
a function of the main target disease (H1N1 or H5N1) in the Wave
2 questionnaire. A MANOVA with target disease as between-
subjects factor (H1N1 or H5N1) and trust in the eight institutions
as dependent variables revealed that overall, trust in institutions
did not differ as a function of target disease, that is whether
questions referred to H5N1 or H1N1 influenza, Wilk’s L= .98,
F(8, 574) = 1.35, ns. Hence, for the analyses reported below, we
aggregated the data across target diseases.
To analyze changes between Waves 1 and 2, we conducted
a MANOVA with wave as within-subjects factor and the eight
trust items as dependent variables. Further, we entered partici-
pants’ gender, subjective health and level of germ aversion and
whether respondents filled out questionnaires of Wave 1 before or
after the emergence of H1N1 as covariates into the analysis, to
control for their potential impact on levels of trust. Results
revealed that overall, trust in institutions decreased significantly
from Wave 1 to Wave 2, Wilk’s L= .84, F(7,561) = 14.73, p,.001
(Figure 2). Univariate analyses showed that trust levels decreased
for all institutions, all Fs.5.12, all ps,.05, except for trust in
governments of countries that are affected by the disease,
F(1,593) = 0.79, ns. Mean levels of trust were highest for medical
organizations, followed by the WHO and the Swiss government.
Interestingly, trust in the media was lowest. Absolute mean-level
decreases in trust from Wave 1 to Wave 2 were largest for the
World Health Organization, the pharmaceutical industry, and
medical organizations (Figure 2).
Perceptions of the Disease Prevention Campaign
We first tested if the role of the media was perceived differently
depending on the target disease in the questionnaire. Results of
a MANOVA with the four disease prevention campaign items as
dependent variables and target disease (H1N1 or H5N1) as
between-subjects independent variable showed that this was not
the case, Wilk’s L=1.0, F(4, 591) = .31, ns, allowing us to
aggregate the data across questionnaires. Descriptive data are
shown in Figure 3. The majority of respondents felt that they had
received enough information from health authorities on the
vaccination procedure (71% responding rather yes or yes) and
indicated having followed the recommendations of the Federal
Office of Public Health (65% responding rather yes or yes).
Nevertheless, 72% of the respondents thought that the vaccine
could have unknown or problematic side effects (responding rather
yes or yes). And 49% did not consider the vaccination useful
(responding rather no or no).
Perceptions of the Role of the Government
Descriptive data are shown in Figure 4. Forty-four percent of
respondents believed that the Swiss government had accentuated
the crisis in order to exhaust Tamiflu stocks (responding rather yes
or yes) and 67% (responding rather yes or yes) felt that the
government had put too much pressure on people to get
vaccinated. Also, 38% (responding rather yes or yes) believed that
the government had omitted or hid some relevant facts.
Table 1. Sample Characteristics Compared to Swiss
Population.
Sample (%) Population (%)a
Sex Male 43.2 49.2
Female 56.8 50.8
Age (yrs) 20–39 35.8 33.7
40–64 46.9 44.9
.65 14 21.4
Residential Area Rural 54.6 26
Urban 45.4 74
Education Secondary 9.6 13
Vocational 57 53
University/college 29.5 34
Monthly Income (CHF) ,3,500 18.3 17
3,501–9,500 65.4 64.9
.9,500 15.9 18.1
Vaccination compliance 17.8b 14–20c
aPopulation data are from the 2008 census conducted by the Swiss Federal
Statistical Office, except for H1N1 vaccination rate. Percentage of population in
each age group is computed relative to the population aged 20 and above in
order to ensure comparability with the age groups sampled.
b[16].
chttp://www.bag.admin.ch/influenza/01120/01134/index.html?lang = fr.
doi:10.1371/journal.pone.0049806.t001
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Perceptions of the Role of the Media
We first tested if the role of the media was perceived differently
depending on the target disease in the questionnaire. Results of
a MANOVA with the four media perception items as dependent
variables and target disease (H1N1 or H5N1) as between-subjects
independent variable showed that this was not the case, Wilk’s
L= .98, F(4, 597) = 2.29, ns, allowing us to aggregate the data
across questionnaires.
Descriptive data are shown in Figure 5. The majority of
respondents (79% responding rather yes or yes) believed that the
media had exaggerated the risk of H1N1 or H5N1. Almost half
(43% responding rather yes or yes) felt that one couldn’t trust what
one heard in the press or disagreed that information in the media
helped avoid an outbreak of cases (43% responding rather no or no).
A sizeable minority (30% responding rather yes or yes) believed that
the media had omitted or hid some relevant facts. However,
respondents also acknowledged the media’s role in drawing
people’s attention to the disease’s dangers (40% responding rather
yes or yes).
Table 2. Correlations Between Main Study Variables.
1. 2. 3. 4. 5. 6. 7. 8.
1. Sex (1 = female, 2 =male)
2. Age W1 .011
3. Subjective Health W1 .047 2.206**
4. Germ aversion W1 2.145** .088* 2.285**
5. W1 survey returned (1 = before outbreak,
2 = after)
2.005 .003 .068 .068
6. W2 survey version (1 =H5N1, 2 =H1N1) 2.009 .003 2.015 .036 .012
7. Trust in institutions W1 2.122** 2.044 .002 .119* .095* .030
8. Trust in institutions W2 2.046 2.033 2.015 .129** 2.003 2.044 .507**
9. Increase in trust from W1to W2 .072 .011 2.011 .019 2.099* 2.073 2.436** .555*
W1: Wave 1. W2: Wave 2.
*p,.05.
**p,.01.
doi:10.1371/journal.pone.0049806.t002
Figure 2. Trust in Institutions, Waves 1 and 2 (error bars indicate one standard deviation).
doi:10.1371/journal.pone.0049806.g002
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Figure 3. Perceptions of the Disease Prevention Campaign, Wave 2.
doi:10.1371/journal.pone.0049806.g003
Figure 4. Perceptions of the Role of the Government, Wave 2.
doi:10.1371/journal.pone.0049806.g004
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Discussion
Our results confirm that public trust is a complex and
multifaceted issue. Participants indicated moderate to high levels
of trust in some institutions, including medical organizations, the
WHO, the Swiss government, the pharmaceutical industry, and
the EU. On the other hand, their trust in others, e.g., in the media,
was low. Moreover, trust in almost all institutions decreased
between the beginning of the outbreak and a year later. The
magnitude of the decrease was particularly high for two
institutions benefiting from a relatively high level of initial trust,
i.e., the WHO and the pharmaceutical industry. This joint
decrease may be due to the allegations of conflict of interest linking
these two actors, allegations that had been covered in the media at
the beginning of 2010, just prior to Wave 2 [12]. Trust in medical
organizations decreased but remained the highest among the
institutions we investigated, corroborating other studies suggesting
that trust in medical professionals is relatively intact [25,7].
Perceptions of the prevention campaign were also multifaceted.
While participants generally were satisfied with the amount of
information received and indicated having followed miscellaneous
recommendations of the Federal Office of Public Health,
widespread concerns about the vaccine were evident. In particular,
a large majority of participants agreed the vaccine might have
unknown or undesirable side effects, echoing highly publicized but
not always accurate popular sentiment about vaccination [10].
Perceptions of the government’s role were characterized by
a substantial degree of mistrust in competence and even in
motives, as evidenced by the relatively high proportions of
participants endorsing the statements that the government may
have applied too much pressure to push the vaccination campaign
or even acted for ulterior motives (e.g., hiding relevant facts,
accentuating the crisis to get rid of excess vaccine stocks). A clear
undercurrent of conspiracy thinking is present in these response
patterns, corroborating other, qualitative studies [21,7]. The
pattern of mistrust also holds for perceptions of the media, who
are largely perceived as crying wolf and also suspected of ulterior
motives.
Our study suffers from some limitations. First, given the
opportunistic nature of our study, we have investigated H5N1
and H1N1 together. These diseases are different in some of their
epidemiological characteristics (e.g., mortality). Nonetheless, they
are similar in terms of the reactions they elicit in laypersons, and
are indistinguishable from one another in the terms of our
analyses. Many studies have shown that public reactions to various
emerging infectious diseases follow similar and predictable
patterns [26]. Second, we have no guarantee that our sample is
representative of the Swiss population. Our results might be biased
in the sense that potential respondents who are especially
mistrustful of public and private institutions may have chosen
not to participate. Our results may thus underestimate the degree
to which mistrust is prevalent. Third, even if our results are not
biased, we cannot guarantee that they will generalize to other
national contexts. Inevitably, the level of trust or mistrust and their
targets will depend on the particulars of each context, including
the orchestration of the vaccination campaign, the characteristics
of local mass media, and other local factors. For example, the
Swiss context is characterized by the presence of several large
pharmaceutical companies, which may affect the public’s attitudes.
For this reason, it is important to conduct similar studies as ours in
other national contexts.
Despite these limitations, results show clear patterns of mistrust
on the part of the public relative to various institutions and their
actions. These results have been tangentially discussed in other
national contexts as well [21], underscoring the importance of
rebuilding trust, especially in the current interpandemic period
and in view of the certain emergence of similar future pandemics
[3]. However, such a process should also be guided by a systematic
research program, which is currently lacking. The study of trust in
the epidemiological context has been to date largely an incidental
concern in existing studies. Three aspects need to be remedied in
our view. First, future research should draw on the sophisticated
conceptual models of trust that exist in the social sciences. A
Figure 5. Perceptions of the Role of the Media, Wave 2.
doi:10.1371/journal.pone.0049806.g005
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distinction should be made between trust in competence and trust
in motives [4,5]. Laypersons may well differ in their attitudes
relative to these particular dimensions for any given institution.
Second, research needs to undertake more differentiated studies of
the targets of trust, i.e., the different institutions, either private or
public, or local, national or international that collaborate in
containing and managing a pandemic, and in communicating with
the public. Many laypersons probably have undifferentiated views
of the institutional actors involved in such situations, and this state
of affairs may facilitate perceptions of collusion or conspiracy
between actors. A particularly important target for future studies
might be trust in front-line health professionals like primary care
physicians or nurses. Indeed, laypersons often turn to such
professionals for advice on interpreting vaccination recommenda-
tions [15]. If these professionals’ own vaccine uptake is low, then
their advice may influence laypersons to not get vaccinated [27].
Results from studies focusing on specific targets of trust can inform
public health communication campaigns, such that more tailored
and participative communication initiatives can be undertaken,
beyond purely ‘‘top-down’’ communication [28]. Third, longitu-
dinal research is needed to investigate dynamic aspects of trust.
While is it obviously not possible any more to design prospective
studies comparing the acute aspects of public reactions during the
pandemic to the current aftermath, archival data, such as internet
postings and online commentary [21] may be amenable to analysis
of longitudinal patterns. Moreover, studies investigating the
evolution of the public’s memories of the pandemic over the
coming years may be important to understand trust-related
reactions to future pandemics.
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